Related Deals
Related Parents
Related Issuers
by Chris Reich
Feb 25, 2026 3:46 PM ET
AstraZeneca Finance LLC (AZN) exp A1/A+ (s/s) US$2bn SEC registered 3-part sr notes (5y FXD due 3/2/31, 7y FXD due 3/2/33 and 10y FXD due 3/2/36). MWC then 1mo par call on 5y (2/2/31), 2mos on 7y (1/2/33) and 3mos on 10y (12/2/35). BofA (B&D)/DB/HSBC/Miz joint active books. Guarantor: AstraZeneca PLC. First Pay: 9/2/26. Day Count: 30/360. Denoms: 2,000 x 1,000. Sales into Canada: Yes, via exemption. Listing: New York Stock Exchange. UOP: General corporate purposes, which may include the refinancing of existing indebtedness. Pricing 2/25. Settle 3/2 (T+3).
IPTs: 5y T+65 area, 7y T+75 area, 10y T+85 area.
GUIDANCE: 5y T+42#, 7y T+52#, 10y T+60#.
LAUNCHED: $650m 5y at T+42, $600m 7y at T+52, $750m 10y at T+60.
PRICED:
$650m 4.00% 3/2/31 99.821 4.040% T+42. MW+10.
$600m 4.30% 3/2/33 99.803 4.333% T+52. MW+10.
$750m 4.60% 3/2/36 99.604 4.650% T+60. MW+10.